Q1. Triglycerides 124. ASCVD risk score is 6.7%. How would you manage this patient? Moderate Intensity 35. A patient on Simvastatin for newly diagnosed hyperlipidemia complains of generalized muscle aches for about 2 weeks. How should this be evaluated?
Q2. In order to reduce lipid levels, statins are the most beneficial when taken: diet and exercise
Q3. A 45 year old diabetic patient with elevated BP. Which medication would you consider first in treating his HTN?
Q4. A 40 year old African American has had BP readings between 135/90 and 144/80 despite his lifestyle modifications for 3 months. What is the appropriate plan of care for this patient?
Q5. When starting patient on ACE inhibitor, which laboratory test would you monitor?
Q6. A 54 year old patient was recently diagnosed with HTN. She was started on Lisinopril 20 mg OD 3 months ago. Her current BP is 156/94. Using the guidelines, what is the appropriate next step?
Q7. Which would represent the best choice of anti-hypertensive agent for the indicated patient's condition?
Q8. Which antihypertensive medication would you avoid using in a patient with severe asthma?
Q9. Which class of anti-hypertensive medication is used to improve long-term outcomes of patients with systolic dysfunction?
Q10. You are trying to determine the thromboembolic risk in a patient with afib. Using the CHADSVASc score, you would consider the following as risk factors except: Age 55
Q11. A patient with new onset Afib has a CHADSVasc score of 4 with no bleeding risks. The best approach for this patient is to:
Q12. A serious complication of deep venous thrombosis is
Q13. A patient presents to the office with left lower leg swelling and discomfort. Based on his history and PE findings, he has a Well's score of 4, what is the most appropriate next step?
Q14. A patient, with no significant co-morbidities, is diagnosed with proximal DVT. A decision has been made to start him on pharmacologic management, the appropriate initial medication and dose to start the patient on is:
Q15. An indicator of severe peripheral arterial disease would be:
Q16. Management of peripheral arterial disease include all of the following except:
Q17. In a patient with an ABI of 0.9, you would recommend:
Q18. In a patient suspected of having PAD, the following statement is true.
Q19. Factors included in the Wells criteria used to evaluate the patient's risk for DVT include